🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,39 USD

Máx. histórico

119,27

4269 días

Caída desde máximo

-69,49%

Rango 52 semanas

18,80 – 36,67

Variación hoy

-0,03%

Cierre anterior

36,40

Rango de hoy

36,39 – 36,41

Volumen hoy

1.075.323

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
103,97 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 2 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/05/2011 10,48 10,57 9,90 10,01 -5,03% 6,39% 51.900
29/04/2011 10,81 10,84 9,86 10,54 +0,29% 9,07% 387.000
28/04/2011 10,68 11,36 10,43 10,51 +1,84% 8,71% 210.000
27/04/2011 9,05 10,39 9,05 10,32 +14,67% 14,81% 437.000
26/04/2011 8,86 9,39 8,54 9,00 +4,17% 9,59% 251.200
25/04/2011 7,87 8,65 7,87 8,64 +9,78% 9,91% 199.300
21/04/2011 7,81 7,90 7,54 7,87 +0,90% 4,61% 53.900
20/04/2011 7,97 7,97 7,38 7,80 +8,48% 7,40% 65.800
19/04/2011 7,16 7,40 7,10 7,19 +0,42% 4,19% 43.000
18/04/2011 7,10 7,25 7,07 7,16 +0,14% 2,54% 59.100
15/04/2011 6,90 7,15 6,90 7,15 +2,88% 3,62% 15.000
14/04/2011 7,02 7,07 6,80 6,95 -1,00% 3,85% 72.400
13/04/2011 7,05 7,06 7,02 7,02 -0,71% 0,57% 16.200
12/04/2011 7,05 7,10 7,02 7,07 +0,14% 1,13% 27.900
11/04/2011 7,10 7,14 7,02 7,06 +0,14% 1,69% 36.000
08/04/2011 7,12 7,14 6,97 7,05 -0,28% 2,39% 39.700
07/04/2011 7,40 7,40 7,07 7,07 -1,26% 4,46% 31.700
06/04/2011 7,12 7,16 7,06 7,16 +1,70% 1,40% 31.100
05/04/2011 7,11 7,21 7,04 7,04 -1,12% 2,39% 46.800
04/04/2011 7,02 7,20 7,02 7,12 +1,28% 2,56% 10.800
01/04/2011 7,18 7,40 7,03 7,03 -0,99% 5,15% 35.100
31/03/2011 7,49 7,59 7,05 7,10 -1,25% 7,21% 71.400
30/03/2011 7,03 7,37 7,00 7,19 +2,42% 5,26% 92.400
29/03/2011 7,10 7,15 7,01 7,02 -0,28% 1,97% 11.400
28/03/2011 7,05 7,12 7,00 7,04 -0,14% 1,70% 15.200
25/03/2011 7,07 7,14 6,96 7,05 -0,28% 2,55% 7.900
24/03/2011 7,10 7,15 7,00 7,07 +0,28% 2,11% 9.400
23/03/2011 7,12 7,12 6,96 7,05 +0,57% 2,25% 19.400
22/03/2011 7,29 7,30 6,99 7,01 +0,14% 4,25% 13.000
21/03/2011 7,12 7,20 7,00 7,00 +0,00% 2,81% 9.300